Birdwatch Archive - Rating Details

Birdwatch Note Rating

2023-08-26 17:11:45 UTC - SOMEWHAT_HELPFUL

Rated by Participant: C0ADD6645272715356F6C51B203BEEF72897776A6A854704712E4D1B253091F0
Participant Details

Original Note:

EBC-46 has shown efficacy to reduce cancer in animal studies only. Clinical trials have since commenced for skin, head and neck, and soft tissue cancers in humans. In 2020 the FDA approved an EBC-46–based medication Stelfonta, to treat mast cell cancer in dogs. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/

All Note Details

Original Tweet

All Information

noteId - 1695190002055970932
participantId -
raterParticipantId - C0ADD6645272715356F6C51B203BEEF72897776A6A854704712E4D1B253091F0
createdAtMillis - 1693069905913
version - 2
agree - 0
disagree - 0
helpful - 0
notHelpful - 0
helpfulnessLevel - SOMEWHAT_HELPFUL
helpfulOther - 0
helpfulInformative - 0
helpfulClear - 0
helpfulEmpathetic - 0
helpfulGoodSources - 0
helpfulUniqueContext - 0
helpfulAddressesClaim - 0
helpfulImportantContext - 0
helpfulUnbiasedLanguage - 1
notHelpfulOther - 0
notHelpfulIncorrect - 0
notHelpfulSourcesMissingOrUnreliable - 0
notHelpfulOpinionSpeculationOrBias - 0
notHelpfulMissingKeyPoints - 0
notHelpfulOutdated - 0
notHelpfulHardToUnderstand - 0
notHelpfulArgumentativeOrBiased - 0
notHelpfulOffTopic - 0
notHelpfulSpamHarassmentOrAbuse - 0
notHelpfulIrrelevantSources - 0
notHelpfulOpinionSpeculation - 0
notHelpfulNoteNotNeeded - 0
ratingsId - 1695190002055970932C0ADD6645272715356F6C51B203BEEF72897776A6A854704712E4D1B253091F0